GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neuronetics Inc (STU:NRC) » Definitions » 5-Year Yield-on-Cost %

Neuronetics (STU:NRC) 5-Year Yield-on-Cost % : 0.00 (As of Mar. 28, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Neuronetics 5-Year Yield-on-Cost %?

Neuronetics's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for Neuronetics's 5-Year Yield-on-Cost % or its related term are showing as below:



STU:NRC's 5-Year Yield-on-Cost % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.25
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Neuronetics's 5-Year Yield-on-Cost %

For the Diagnostics & Research subindustry, Neuronetics's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuronetics's 5-Year Yield-on-Cost % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Neuronetics's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Neuronetics's 5-Year Yield-on-Cost % falls into.


;
;

Neuronetics 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Neuronetics is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Neuronetics  (STU:NRC) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Neuronetics 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Neuronetics's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Neuronetics Business Description

Traded in Other Exchanges
Address
3222 Phoenixville Pike, Malvern, PA, USA, 19355
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.